Overview
Title
To amend the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize the residential substance use disorder treatment program, and for other purposes.
ELI5 AI
S. 3740, the STRONGER Act, is like a big helping hand to make sure people in jail with problems due to drugs can get better. It plans to give $40 million every year to help them learn about and use special medicines and programs to feel healthy again.
Summary AI
S. 3740, also known as the "STRONGER Act," proposes amendments to the Omnibus Crime Control and Safe Streets Act of 1968. It aims to reauthorize and enhance the residential substance use disorder treatment program by updating terminology, expanding treatment options to include medication-assisted programs, and requiring staff training on addiction science and treatment strategies. The bill also ensures local correctional facilities receive a portion of funding and defines medication-assisted treatment as combining behavioral therapy with medications approved by the FDA. Additionally, it authorizes $40 million annually from 2025 to 2029 for these initiatives.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
General Summary of the Bill
The proposed legislation, titled the "Supporting Treatment and Recovery Over Narcotics for Growth, Empowerment, and Rehabilitation Act" or "STRONGER Act," seeks to amend the Omnibus Crime Control and Safe Streets Act of 1968. The primary aim of this bill is to reauthorize and update the residential substance use disorder treatment program. Key revisions include replacing the term "substance abuse" with "substance use disorder" to align with modern clinical parlance and expanding the scope of medication-assisted treatments available in residential treatment programs. Additionally, the bill mandates training for relevant prison or jail personnel on various aspects of addiction science and treatment protocols, along with establishing affiliations with healthcare providers who can continue care post-incarceration.
Summary of Significant Issues
A notable issue with the proposed legislation is the lack of clarity regarding the timeframe for training completion by medical staff in correctional facilities. The term "reasonable amount of time" is ambiguous and could result in delays or lack of accountability in implementing essential training. Similarly, while the updated language reflects current clinical terminology, it may cause inconsistencies or confusion due to prior legislative terms not being aligned.
Another critical point is financial; the bill allocates a set budget of $40 million annually over five years but does not account for inflation or variable program needs during this period. Furthermore, the bill uses guidelines from 2017 without a mechanism for updating them, which risks promoting outdated practices as standards of care evolve.
Impact on the Public and Stakeholders
Broad Public Impact
The STRONGER Act potentially has a broad positive impact by modernizing and improving the language and application of treatments for substance use disorders, recognizing the problem with appropriate contemporary terminology. This could foster a greater public understanding and reduce stigma associated with addiction issues. Moreover, if successfully implemented, the bill may enhance the effectiveness of substance use disorder treatment, contributing to overall public health and safety improvements.
Impact on Specific Stakeholders
Correctional Facilities and Personnel: The requirement for training on addiction science for medical officers and staff signifies a considerable operational shift. While enhancing care standards, this may necessitate additional resources and planning to implement effectively. Ambiguities about training completion deadlines and compliance monitoring could also create operational and accountability challenges.
Healthcare Providers: Affiliations mandated between correctional facilities and external healthcare providers aim to ensure continuity of care post-incarceration. This could open up opportunities for these providers but will also necessitate increased collaboration and potentially additional administrative efforts.
Local correctional and detention facilities: The allocation of 10% of funds needs clear guidance to avoid unequal resource distribution and to ensure effective application at the local level. This could pose challenges in effectively utilizing funds in a manner that equitably serves diverse community needs.
Legislators and Policymakers: The shift in terminology and treatment protocols will require policymakers to reassess and align existing laws and practices with the updated language and approaches, potentially involving a review of other related policies and regulations to ensure consistency.
Overall, while the STRONGER Act proposes meaningful updates to address substance use disorder treatment, it necessitates careful consideration and planning regarding implementation timelines, financial adjustments, and consistent application of current care standards.
Financial Assessment
The proposed bill, S. 3740, known as the "STRONGER Act," outlines a series of amendments aimed at improving treatment programs for individuals with substance use disorders. A critical component of this bill involves financial appropriations dedicated to these initiatives.
Financial Summary and Allocation
Central to the financial aspect of the bill is the authorization of $40 million per year from 2025 to 2029 to support the programs under Part S of the Omnibus Crime Control and Safe Streets Act of 1968. This consistent annual funding aims to ensure that the initiatives, particularly those related to residential substance use disorder treatment, are adequately supported over the designated period.
Relating Financial Allocations to Identified Issues
Fixed Annual Funding: The bill’s provision of $40 million annually for fiscal years 2025 through 2029 does not take into account potential variations in program needs over time or inflation. This static allocation could potentially lead to financial imprudence, where future program challenges or successes could inform better funding decisions. Programs might face budgetary constraints if the cost of services increases or if expanded services require additional funding beyond what is statically allocated. Addressing this issue would require incorporating flexibility or contingencies within the financial plan.
Local Facility Funding: The bill mandates that at least 10% of the state-allocated funds each fiscal year be directed towards local correctional and detention facilities. There appears to be no specific guideline in the bill regarding how these allocations will be monitored or audited to ensure fair distribution and effective use. This lack of oversight mechanism might result in unequal distribution of funds among facilities, potentially impacting the quality of available programs.
Program Adaptability: While financially supporting medication-assisted treatments, the bill's current definition focuses on existing FDA-approved treatments. There is a concern that this may restrict the adoption of emerging treatments and technologies that could be relevant in the future. The financial allocations do not provide a clear pathway for adapting to advancements in care, which could limit the effectiveness of the programs over time.
Accountability and Compliance: Although the bill sets the framework for training requirements, it lacks details on how compliance will be enforced or monitored from a financial perspective. Without specific accountability measures, there is a risk that the allocated funds may not achieve the desired improvements in staff training and program effectiveness.
In summary, while the STRONGER Act earmarks significant financial resources towards improving substance use disorder treatment programs, it does raise several financial-related issues. These include potential misalignments due to static funding across several years, lack of oversight in fund allocation to local facilities, potential constraints on adopting new treatment technologies, and insufficient mechanisms for ensuring compliance with training requirements. Addressing these issues could enhance the program’s adaptability and effectiveness in responding to the evolving landscape of substance use disorder treatment.
Issues
The requirement for completion of training by the chief medical officer or appropriate staff before or within a 'reasonable amount of time' after receiving funds is vague. Without a specific timeframe, this could lead to delays in implementation and lack of accountability, as reflected in Section 2, amendments to Part S, section 1902(g).
The use of 'substance use disorder' instead of 'substance abuse' represents a positive alignment with contemporary clinical terminology; however, this may cause misalignment with previous legislative language and understanding, as noted in Section 2 amendments affecting multiple subsections (e.g., sections 1901, 1902).
The consistent allocation of $40,000,000 each year from 2025 to 2029 does not account for inflation, changes in program needs, or adjustments based on program implementation success or failures, leading to potential financial imprudence, as indicated in Section 2, amendments to section 1001(a)(17).
The definition of 'medication-assisted treatment' does not encompass emerging treatments or technologies that could be relevant in the future, potentially restricting adaptability and responsiveness to advancements in care, as noted in amendments to sections 1901 and 1904(d).
The lack of specificity on how the compliance with the training requirements will be monitored or enforced creates a gap in ensuring accountability and effectiveness as reflected in Section 2, amendments to section 1902(g).
There is no guideline on how the allocation of at least 10% of funds to local correctional and detention facilities will be monitored to ensure equitable distribution or effective use, as raised in Section 2, amendments to section 1904(c).
The use of guidelines from 2017, without a mechanism for updates to ensure alignment with evolving care standards, is problematic, which may lead to outdated practices being followed, as indicated in the definition amendment to section 901(25).
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The section provides the official short title of the legislation, which is called the “Supporting Treatment and Recovery Over Narcotics for Growth, Empowerment, and Rehabilitation Act” or the “STRONGER Act.”
2. Residential substance use disorder treatment program Read Opens in new tab
Summary AI
The provided amendments to the Omnibus Crime Control and Safe Streets Act of 1968 emphasize shifting the terminology from "substance abuse" to "substance use disorder" and expand the use of medication-assisted treatments in residential treatment programs. Additionally, the amendments require training for relevant staff on addiction science and treatment protocols, along with the establishment of affiliations with providers who can prescribe treatments after incarceration.
Money References
- (b) Authorization of appropriations.—Section 1001(a)(17) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10261(a)(17)) is amended to read as follows: “(17) There are authorized to be appropriated to carry out the projects under part S $40,000,000 for each of fiscal years 2025 through 2029.”